Event detail

BioTrinity is the leading European Biopartnering and Investment Conference.  It provides the best opportunity to meet investors, senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies, many of whom present in the company showcase tracks.

Now in its 9th year, over 130 investor delegates from more than 100 firms are expected to attend BioTrinity 2015 from active VC and Corporate Venture firms. In 2014 we hosted 2,462 one-to-one meetings over two days between 1,014 delegates from 32 countries, representing more than 624 companies.

More information about Bio Trinity 2015 and registration link you will find here.